{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T21:28:36Z","timestamp":1771190916340,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Senior Clinical Lecturer","award":["ICA-SCL-2018-04-ST2-004"],"award-info":[{"award-number":["ICA-SCL-2018-04-ST2-004"]}]},{"name":"Health Education England"},{"name":"National Institute for Health"},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","award":["2017\u20132022"],"award-info":[{"award-number":["2017\u20132022"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20015; 2022\u20132027"],"award-info":[{"award-number":["IS-BRC-1215-20015; 2022\u20132027"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203331"],"award-info":[{"award-number":["NIHR203331"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We aimed to develop a prediction model identifying people presenting to primary care with musculoskeletal symptoms likely to be anti-CCP positive and therefore at risk of developing RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Participants aged \u226516\u2009years, with new-onset non-specific musculoskeletal symptoms and no history of clinical synovitis, completed a symptom questionnaire and had an anti-CCP test. Model development used LASSO-penalized logistic regression, performance was assessed using area under the receiver operating characteristic curve (AUROC) and decision curve analysis, model over-fit was estimated using bootstrapping and cross-validation. Participants were followed-up at 12\u2009months for RA or seronegative\/undifferentiated inflammatory arthritis diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Analysis included 6879 participants; 203 (2.95%) of whom were anti-CCP positive. Eleven predictors were retained: male sex, first-degree relative with RA, ever smoked and joint pain in: back, neck, shoulders, wrists, hands\/fingers, thumbs, knees, feet\/toes. AUROC was 0.65 (95% CI 0.61, 0.69, optimism\u2009=\u20090.03). Using a 4% decision threshold, the model recommended an anti-CCP test in 1288 (18.7%) participants, 78 (6.1%) of whom were anti-CCP positive, compared with 125\/5591 (2.2%) below the threshold. Net benefit was 0.0040 (0.0020 corrected). Forty-eight participants were diagnosed with inflammatory arthritis\/RA within 12\u2009months. Of those who were above the threshold and anti-CCP positive, 32.1% developed inflammatory arthritis\/RA compared with 0.4% of those who were anti-CCP negative. Of those below the threshold, 0.3% were diagnosed with inflammatory arthritis\/RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Targeted anti-CCP testing in primary care may aid earlier identification of people at risk of RA, prompting specialist referral to rheumatology for earlier diagnosis and initiation of disease-modifying therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae653","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T19:21:14Z","timestamp":1733858474000},"page":"3947-3956","source":"Crossref","is-referenced-by-count":2,"title":["A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary care"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-332X","authenticated-orcid":false,"given":"Heidi J","family":"Siddle","sequence":"first","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7556-1599","authenticated-orcid":false,"given":"Michelle","family":"Wilson","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-7922","authenticated-orcid":false,"given":"Jacqueline L","family":"Nam","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1806-7532","authenticated-orcid":false,"given":"Leticia","family":"Garcia-Montoya","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"NIHR Leeds Biomedical Research Centre , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-0986","authenticated-orcid":false,"given":"Laurence","family":"Duquenne","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"NIHR Leeds Biomedical Research Centre , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7945-6582","authenticated-orcid":false,"given":"Kulveer","family":"Mankia","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"NIHR Leeds Biomedical Research Centre , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-8482","authenticated-orcid":false,"given":"Paul","family":"Emery","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"NIHR Leeds Biomedical Research Centre , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-4755","authenticated-orcid":false,"given":"Elizabeth M A","family":"Hensor","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"NIHR Leeds Biomedical Research Centre , Leeds,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"2025052703533561500_keae653-B1","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(87)91672-2","article-title":"Long-term outcome of treating rheumatoid arthritis: results after 20 years","volume":"1","author":"Scott","year":"1987","journal-title":"Lancet"},{"key":"2025052703533561500_keae653-B2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/art.1780290602","article-title":"Survival, prognosis, and causes of death in rheumatoid arthritis","volume":"29","author":"Mitchell","year":"1986","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.1780270805","article-title":"Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years","volume":"27","author":"Pincus","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B4","first-page":"888","article-title":"Rheumatoid arthritis and comorbidity","volume":"17","author":"Berkanovic","year":"1990","journal-title":"J Rheumatol"},{"key":"2025052703533561500_keae653-B5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B6","doi-asserted-by":"crossref","first-page":"100519","DOI":"10.1016\/j.lanepe.2022.100519","article-title":"Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data","volume":"23","author":"Scott","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2025052703533561500_keae653-B7","author":"National Audit Office","year":"2009"},{"key":"2025052703533561500_keae653-B8","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1002\/art.11439","article-title":"Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients","volume":"48","author":"Michaud","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B9","author":"Versus Arthritis","year":"2023"},{"key":"2025052703533561500_keae653-B10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-124-8-199604150-00001","article-title":"The effectiveness of early treatment with \"second-line\" antirheumatic drugs. A randomized, controlled trial","volume":"124","author":"van der Heide","year":"1996","journal-title":"Ann Intern Med"},{"key":"2025052703533561500_keae653-B11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.10727","article-title":"Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study","volume":"48","author":"Bukhari","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B12","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.22525","article-title":"Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial","volume":"56","author":"van Dongen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.22353","article-title":"Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis","volume":"55","author":"Finckh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9343(01)00872-5","article-title":"Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies","volume":"111","author":"Lard","year":"2001","journal-title":"Am J Med"},{"key":"2025052703533561500_keae653-B15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","article-title":"How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis","volume":"46","author":"Visser","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/art.22380","article-title":"A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions","volume":"56","author":"van der Helm-van Mil","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B17","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025052703533561500_keae653-B18","doi-asserted-by":"crossref","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"2025052703533561500_keae653-B19","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025052703533561500_keae653-B20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"key":"2025052703533561500_keae653-B21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(23)02649-1","article-title":"Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial","volume":"403","author":"Cope","year":"2024","journal-title":"Lancet"},{"key":"2025052703533561500_keae653-B22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","article-title":"Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial","volume":"403","author":"Rech","year":"2024","journal-title":"Lancet"},{"key":"2025052703533561500_keae653-B23","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025052703533561500_keae653-B24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025052703533561500_keae653-B25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/annrheumdis-2015-207871","article-title":"Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms\u2014a cohort study","volume":"75","author":"Nam","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025052703533561500_keae653-B26","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1136\/annrheumdis-2015-208235","article-title":"Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis","volume":"75","author":"Nam","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025052703533561500_keae653-B27","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7326\/M23-0272","article-title":"Predicting inflammatory arthritis in at-risk persons: development of scores for risk stratification","volume":"176","author":"Duquenne","year":"2023","journal-title":"Ann Intern Med"},{"key":"2025052703533561500_keae653-B28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2474-11-144","article-title":"Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study","volume":"11","author":"Jordan","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"2025052703533561500_keae653-B29","author":"NICE","year":"2018"},{"key":"2025052703533561500_keae653-B30","doi-asserted-by":"crossref","first-page":"e54878","DOI":"10.1371\/journal.pone.0054878","article-title":"Optimising use of electronic health records to describe the pesentation of rheumatoid arthritis in primary care: a strategy for developing code lists","volume":"8","author":"Nicholson","year":"2013","journal-title":"PLoS ONE"},{"key":"2025052703533561500_keae653-B31","doi-asserted-by":"crossref","first-page":"e009309","DOI":"10.1136\/bmjopen-2015-009309","article-title":"An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study","volume":"5","author":"Muller","year":"2015","journal-title":"BMJ Open"},{"key":"2025052703533561500_keae653-B32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2296-14-150","article-title":"Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study","volume":"14","author":"Monk","year":"2013","journal-title":"BMC Fam Pract"},{"key":"2025052703533561500_keae653-B33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/L15-5093-2","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"2025052703533561500_keae653-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"2025052703533561500_keae653-B35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-0-387-77244-8","volume-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"Steyerberg","year":"2009"},{"key":"2025052703533561500_keae653-B36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2025052703533561500_keae653-B37","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II\u2014binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat Med"},{"key":"2025052703533561500_keae653-B38","author":"Ensor","year":"2021"},{"key":"2025052703533561500_keae653-B39","author":"Sjoberg","year":"2022"},{"key":"2025052703533561500_keae653-B40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"2025052703533561500_keae653-B41"},{"key":"2025052703533561500_keae653-B42"},{"key":"2025052703533561500_keae653-B43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/09332480.2019.1579578","article-title":"A second chance to get causal inference right: a classification of data science tasks","volume":"32","author":"Hern\u00e1n","year":"2019","journal-title":"Chance"},{"key":"2025052703533561500_keae653-B44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9681(79)90012-2","article-title":"Bias in analytic research","volume":"32","author":"Sackett","year":"1979","journal-title":"J Chronic Dis"},{"key":"2025052703533561500_keae653-B45","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226286","article-title":"Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial","author":"van Mulligen","journal-title":"Ann Rheum Dis"},{"key":"2025052703533561500_keae653-B46","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","article-title":"Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis","volume":"43","author":"Nell","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"2025052703533561500_keae653-B47","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2024-225746","article-title":"Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?","volume":"83","author":"van Mulligen","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025052703533561500_keae653-B48","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002606","article-title":"Predictors of perceived risk in first-degree relatives of patients with rheumatoid arthritis","volume":"8","author":"Bunnewell","year":"2022","journal-title":"RMD Open"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae653\/60951335\/keae653.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/3947\/60951335\/keae653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/3947\/60951335\/keae653.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T07:53:54Z","timestamp":1748332434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/6\/3947\/7916505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,4]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae653","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2024,12,4]]}}}